Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration.

@article{Ct2017IncidenceRF,
  title={Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration.},
  author={Nancy C{\^o}t{\'e} and Philippe Pibarot and Marie-Annick Clavel},
  journal={Current opinion in cardiology},
  year={2017},
  volume={32 2},
  pages={
          123-129
        }
}
PURPOSE OF REVIEW Structural valve deterioration is the major cause of bioprosthesis failure and is increasing over time. We present an overview of incidence, mechanisms, predictors, clinical impact, and management of bioprosthetic valve structural degeneration. RECENT FINDINGS Early degeneration caused by calcification and destruction of connective tissue of the prosthesis is controlled by multiple mechanisms, from mechanical stress to infiltration of lipids and inflammatory cells, and… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 81 REFERENCES

ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration.

  • Journal of the American College of Cardiology
  • 2013
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Late incidence and determinants of reoperation in patients with prosthetic heart valves.

  • European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • 2004
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…